1. Home
  2. HROW vs CIM Comparison

HROW vs CIM Comparison

Compare HROW & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • CIM
  • Stock Information
  • Founded
  • HROW 1998
  • CIM 2007
  • Country
  • HROW United States
  • CIM United States
  • Employees
  • HROW N/A
  • CIM N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • CIM Real Estate Investment Trusts
  • Sector
  • HROW Health Care
  • CIM Real Estate
  • Exchange
  • HROW Nasdaq
  • CIM Nasdaq
  • Market Cap
  • HROW 1.0B
  • CIM 1.1B
  • IPO Year
  • HROW N/A
  • CIM 2007
  • Fundamental
  • Price
  • HROW $24.98
  • CIM $12.76
  • Analyst Decision
  • HROW Strong Buy
  • CIM Hold
  • Analyst Count
  • HROW 5
  • CIM 2
  • Target Price
  • HROW $58.40
  • CIM $16.00
  • AVG Volume (30 Days)
  • HROW 691.9K
  • CIM 581.6K
  • Earning Date
  • HROW 05-12-2025
  • CIM 05-08-2025
  • Dividend Yield
  • HROW N/A
  • CIM 11.64%
  • EPS Growth
  • HROW N/A
  • CIM 61.77
  • EPS
  • HROW N/A
  • CIM 1.10
  • Revenue
  • HROW $199,614,000.00
  • CIM $277,886,000.00
  • Revenue This Year
  • HROW $45.63
  • CIM $9.17
  • Revenue Next Year
  • HROW $38.04
  • CIM $1.73
  • P/E Ratio
  • HROW N/A
  • CIM $11.56
  • Revenue Growth
  • HROW 53.32
  • CIM 22.95
  • 52 Week Low
  • HROW $9.86
  • CIM $11.29
  • 52 Week High
  • HROW $59.23
  • CIM $16.89
  • Technical
  • Relative Strength Index (RSI)
  • HROW 41.63
  • CIM 28.12
  • Support Level
  • HROW $25.17
  • CIM $12.54
  • Resistance Level
  • HROW $30.73
  • CIM $13.37
  • Average True Range (ATR)
  • HROW 2.18
  • CIM 0.26
  • MACD
  • HROW 0.20
  • CIM -0.06
  • Stochastic Oscillator
  • HROW 31.23
  • CIM 16.41

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

About CIM Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Share on Social Networks: